Intuitive's sales and profits exceeded expectations, but a warning about Trump's import tax proposal may have worried ...

RevMedica announced that the FDA accepted its Endo stapling platform into its Safer Technologies Program (STeP).

A federal judge rejected Intuitive's request to end an antitrust trial. The case involves third-party servicing of robotic surgery tools.

Siemens Healthineers announced that an Iowa healthcare facility became the first in the U.S. to install its new Mammomat B.brilliant.

Vantis Vascular announced today announced the first commercial use of its CrossFast integrated microcatheter advanced delivery system.